Information Journal Paper
APA:
Copy. (2017). Healthcare costs and utilization for patients age 50 to 64 years with acute myeloid leukemia treated with chemotherapy or with chemotherapy and allogeneic hematopoietic cell transplantation. BIOL BLOOD MARROW TRANSPLANT, 23(6), 1021-1028. SID. https://sid.ir/paper/732458/en
Vancouver:
Copy. Healthcare costs and utilization for patients age 50 to 64 years with acute myeloid leukemia treated with chemotherapy or with chemotherapy and allogeneic hematopoietic cell transplantation. BIOL BLOOD MARROW TRANSPLANT[Internet]. 2017;23(6):1021-1028. Available from: https://sid.ir/paper/732458/en
IEEE:
Copy, “Healthcare costs and utilization for patients age 50 to 64 years with acute myeloid leukemia treated with chemotherapy or with chemotherapy and allogeneic hematopoietic cell transplantation,” BIOL BLOOD MARROW TRANSPLANT, vol. 23, no. 6, pp. 1021–1028, 2017, [Online]. Available: https://sid.ir/paper/732458/en